"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on the U.S. Food and Drug Administration Approval for Marketing of Insulin Aspart Injection

Announcement on the U.S. Food and Drug Administration Approval for Marketing of Insulin Aspart Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment